These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder. Jabben N, Arts B, van Os J, Krabbendam L. J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370 [Abstract] [Full Text] [Related]
3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B. Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [Abstract] [Full Text] [Related]
5. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders]. Liraud F, Verdoux H. Encephale; 2002 Dec; 28(2):160-8. PubMed ID: 11972143 [Abstract] [Full Text] [Related]
6. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Altshuler LL, Ventura J, van Gorp WG, Green MF, Theberge DC, Mintz J. Biol Psychiatry; 2004 Oct 15; 56(8):560-9. PubMed ID: 15476685 [Abstract] [Full Text] [Related]
10. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis. Mata I, Rodríguez-Sánchez JM, Pelayo-Terán JM, Pérez-Iglesias R, González-Blanch C, Ramírez-Bonilla M, Martínez-García O, Vázquez-Barquero JL, Crespo-Facorro B. Psychol Med; 2008 Sep 15; 38(9):1257-66. PubMed ID: 18005495 [Abstract] [Full Text] [Related]
11. Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. Torres IJ, DeFreitas VG, DeFreitas CM, Kauer-Sant'Anna M, Bond DJ, Honer WG, Lam RW, Yatham LN. J Clin Psychiatry; 2010 Sep 15; 71(9):1234-42. PubMed ID: 20361907 [Abstract] [Full Text] [Related]
12. Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder. Ringen PA, Melle I, Berg AO, Agartz I, Spigset O, Simonsen C, Sundet K, Andreassen OA. Schizophr Res; 2013 Jan 15; 143(1):84-9. PubMed ID: 23178107 [Abstract] [Full Text] [Related]
13. Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia. Scholes KE, Martin-Iverson MT. Psychol Med; 2010 Oct 15; 40(10):1635-46. PubMed ID: 20018124 [Abstract] [Full Text] [Related]
16. Neuropsychological and electrophysiological indices of neurocognitive dysfunction in bipolar II disorder. Andersson S, Barder HE, Hellvin T, Løvdahl H, Malt UF. Bipolar Disord; 2008 Dec 15; 10(8):888-99. PubMed ID: 19594504 [Abstract] [Full Text] [Related]
17. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates. Brissos S, Dias VV, Carita AI, Martinez-Arán A. Psychiatry Res; 2008 Jul 15; 160(1):55-62. PubMed ID: 18485488 [Abstract] [Full Text] [Related]
18. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH. Aust N Z J Psychiatry; 2010 Mar 15; 44(3):230-6. PubMed ID: 20180725 [Abstract] [Full Text] [Related]
19. Dissociable mechanisms for memory impairment in bipolar disorder and schizophrenia. Glahn DC, Barrett J, Bearden CE, Mintz J, Green MF, Serap Monkul E, Najt P, Soares JC, Velligan DI. Psychol Med; 2006 Aug 15; 36(8):1085-95. PubMed ID: 16734948 [Abstract] [Full Text] [Related]